| Entry |
|
| Name |
Dopamine beta-hydroxylase deficiency;
Norepinephrine deficiency;
Noradrenaline deficiency
|
| Description |
Dopamine beta-hydroxylase (DBH) deficiency is a very rare form of primary autonomic failure characterized by cardiovascular disorders and severe orthostatic hypotension. DBH deficiency is caused by a series of mutations in the DBH gene encoding the key enzyme in noradrenaline synthesis.
|
| Category |
Nervous system disease
 |
| Pathway |
|
| Gene |
|
| Marker |
Complete absence of noradrenaline and adrenaline in plasma.
Increased dopamine plasma levels.
|
| Drug |
|
| Other DBs |
|
| Reference |
|
| Authors |
Robertson D, Garland EM |
| Title |
Dopamine Beta-Hydroxylase Deficiency |
| Journal |
(1993) |
| Reference |
|
| Authors |
Senard JM, Rouet P |
| Title |
Dopamine beta-hydroxylase deficiency. |
| Journal |
Orphanet J Rare Dis 1:7 (2006) |